Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and Carcinoma, Non-Small Cell Lung

idarubicin has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mumper, RJ; Wadhwa, S1
Felder, TB; Jeffries, D; Newman, RA; Umsawasdi, T1
Blum, R; Chang, AY; Donehower, RC; Ettinger, DS; Finkelstein, DM; Green, M; Hahn, RG; Ruckdeschel, JC1
Carr, DT; Holoye, PY; Jeffries, D; Umsawasdi, T1
Ardizzoni, A; Canobbio, L; De Palma, M; Fusco, V; Ganzina, F; Gulisano, M; Pronzato, P; Repetto, L; Rosso, R1
Bell, D; Kefford, R; Levi, J; Presgrave, P; Raghavan, D; Woods, R1
Ardizzoni, A; Conte, P; Fusco, V; Gulisano, M; Lionetto, R; Pronzato, P; Repetto, L; Rosso, R1

Trials

1 trial(s) available for idarubicin and Carcinoma, Non-Small Cell Lung

ArticleYear
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study.
    Medical and pediatric oncology, 1989, Volume: 17, Issue:3

    Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Formamides; Germanium; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Prognosis; Random Allocation; Remission Induction; Spiro Compounds

1989

Other Studies

6 other study(ies) available for idarubicin and Carcinoma, Non-Small Cell Lung

ArticleYear
Polypeptide conjugates of D-penicillamine and idarubicin for anticancer therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Mar-10, Volume: 158, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Idarubicin; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Penicillamine; Peptides; Polyglutamic Acid; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays

2012
Phase II study of 4-demethoxydaunorubicin in previously untreated extensive disease non-small cell lung cancer.
    Investigational new drugs, 1990, Volume: 8 Suppl 1

    Topics: Adult; Aged; Biological Availability; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged

1990
Phase II study of idarubicin in extensive-disease non-small-cell lung cancer.
    American journal of clinical oncology, 1989, Volume: 12, Issue:6

    Topics: Adolescent; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged

1989
Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC).
    Cancer investigation, 1988, Volume: 6, Issue:4

    Topics: Administration, Oral; Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged

1988
A phase II trial of oral 4'demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancer.
    Investigational new drugs, 1988, Volume: 6, Issue:3

    Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged

1988
Phase II trials of idarubicin, a new anthracycline.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged

1987